| |
| |
|
| Insider
Information: |
Dunton Alan W |
| Relationship: |
|
| City: |
King Of Prussia |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
1,041,878 |
|
|
Indirect Shares
|
7,520 |
|
|
| Direct
Value |
$159,923 |
|
|
|
Indirect Value
|
$13,701 |
|
|
| Total
Shares |
1,049,398 |
|
|
| Total
Value |
$173,625 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
1
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
3.0
|
-1.0
|
| Percentage
Gain/Loss : |
 66.8%
|
 -17.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adams Respiratory Therapeutics, ... |
ARXT |
Director |
2008-01-29 |
0 |
2007-01-03 |
0 |
Premium* |
|
|
Panacos Pharma Inc |
PANC |
Chief Exec Officer & P... |
2008-04-30 |
240,865 |
2007-08-03 |
0 |
Premium* |
|
|
Gyre Therapeutics |
GYRE |
Director |
2014-12-11 |
10,000 |
2010-07-15 |
0 |
Premium* |
|
|
Palatin Technologies Inc |
PTN |
|
2023-12-04 |
45,074 |
2013-03-19 |
7,520 |
Premium* |
|
|
Oragenics Inc |
OGEN |
Director |
2023-08-08 |
25,689 |
2011-11-14 |
0 |
Premium* |
|
|
Epicept Corp |
IMNP |
Director |
2013-08-12 |
705,000 |
2012-01-03 |
0 |
Premium* |
|
|
Cormedix Inc. |
CRMD |
|
2023-12-15 |
15,250 |
2019-07-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
83 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OGEN |
Oragenics Inc |
Director |
– • – |
2013-12-20 |
4 |
S |
$2.85 |
$28,592 |
D/D |
(10,000) |
89,063 |
0 |
- |
|
| OGEN |
Oragenics Inc |
Director |
– • – |
2015-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,100 |
92,588 |
0 |
- |
|
| OGEN |
Oragenics Inc |
Director |
– • – |
2013-12-18 |
4 |
S |
$2.82 |
$14,100 |
D/D |
(5,000) |
99,063 |
0 |
- |
|
| OGEN |
Oragenics Inc |
Director |
– • – |
2013-12-17 |
4 |
S |
$2.84 |
$11,361 |
D/D |
(4,000) |
104,063 |
0 |
- |
|
| OGEN |
Oragenics Inc |
Director |
– • – |
2015-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
107,688 |
0 |
- |
|
| OGEN |
Oragenics Inc |
Director |
– • – |
2013-12-13 |
4 |
S |
$3.00 |
$12,000 |
D/D |
(4,000) |
108,063 |
0 |
- |
|
| OGEN |
Oragenics Inc |
Director |
– • – |
2013-12-12 |
4 |
S |
$3.00 |
$9,000 |
D/D |
(3,000) |
112,063 |
0 |
- |
|
| OGEN |
Oragenics Inc |
Director |
– • – |
2013-12-11 |
4 |
S |
$3.03 |
$9,090 |
D/D |
(3,000) |
115,063 |
0 |
- |
|
| PTN |
Palatin Technologies Inc |
Director |
• • – |
2015-06-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
116,686 |
0 |
- |
|
| OGEN |
Oragenics Inc |
Director |
– • – |
2013-12-10 |
4 |
S |
$3.00 |
$4,500 |
D/D |
(1,500) |
118,063 |
0 |
- |
|
| OGEN |
Oragenics Inc |
Director |
– • – |
2013-12-09 |
4 |
S |
$3.11 |
$4,665 |
D/D |
(1,500) |
119,563 |
0 |
- |
|
| OGEN |
Oragenics Inc |
Director |
– • – |
2013-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
38,397 |
121,063 |
0 |
- |
|
| OGEN |
Oragenics Inc |
Director |
– • – |
2016-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
132,588 |
0 |
- |
|
| PANC |
Panacos Pharma Inc |
Chief Exec Officer & President |
• • – |
2007-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
140,865 |
0 |
- |
|
| PANC |
Panacos Pharma Inc |
Chief Exec Officer & President |
• • – |
2008-02-13 |
4/A |
A |
$0.00 |
$0 |
D/D |
100,000 |
140,865 |
0 |
- |
|
| PTN |
Palatin Technologies Inc |
Director |
• • – |
2015-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
166,686 |
0 |
- |
|
| OGEN |
Oragenics Inc |
Director |
– • – |
2017-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
172,588 |
0 |
- |
|
| PTN |
Palatin Technologies Inc |
Director |
• • – |
2016-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
175,645 |
0 |
- |
|
| PTN |
Palatin Technologies Inc |
Director |
• • – |
2016-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
195,645 |
0 |
- |
|
| PANC |
Panacos Pharma Inc |
Chief Exec Officer & President |
• • – |
2008-04-30 |
4/A |
B |
$0.46 |
$46,210 |
D/D |
100,000 |
240,865 |
2.81 |
- |
|
| PANC |
Panacos Pharma Inc |
Chief Exec Officer & President |
• • – |
2008-04-30 |
4 |
A |
$0.46 |
$46,210 |
D/D |
100,000 |
240,865 |
0 |
- |
|
| PTN |
Palatin Technologies Inc |
|
– • – |
2017-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
54,000 |
308,520 |
0 |
- |
|
| PTN |
Palatin Technologies Inc |
|
– • – |
2017-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
331,520 |
0 |
- |
|
| PTN |
Palatin Technologies Inc |
|
– • – |
2018-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
408,353 |
0 |
- |
|
| PTN |
Palatin Technologies Inc |
|
– • – |
2018-11-15 |
4 |
B |
$0.80 |
$266 |
D/D |
332 |
412,351 |
0.01 |
- |
|
83 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
